Your browser doesn't support javascript.
loading
Neutralizing effects of anti-infliximab antibodies on synergistically-stimulated human coronary artery endothelial cells.
Ogric, Manca; Poljsak, Katjusa Mrak; Lakota, Katja; Zigon, Polona; Praprotnik, Sonja; Semrl, Snezna Sodin; Cucnik, Sasa.
Afiliación
  • Ogric M; University Medical Centre Ljubljana, Department of Rheumatology, Ljubljana, Slovenia; University of Ljubljana, Faculty of Pharmacy, Chair of Clinical Biochemistry, Ljubljana, Slovenia.
  • Poljsak KM; University Medical Centre Ljubljana, Department of Rheumatology, Ljubljana, Slovenia.
  • Lakota K; University Medical Centre Ljubljana, Department of Rheumatology, Ljubljana, Slovenia; University of Primorska, FAMNIT, Koper, Slovenia.
  • Zigon P; University Medical Centre Ljubljana, Department of Rheumatology, Ljubljana, Slovenia.
  • Praprotnik S; University Medical Centre Ljubljana, Department of Rheumatology, Ljubljana, Slovenia.
  • Semrl SS; University Medical Centre Ljubljana, Department of Rheumatology, Ljubljana, Slovenia; University of Primorska, FAMNIT, Koper, Slovenia.
  • Cucnik S; University Medical Centre Ljubljana, Department of Rheumatology, Ljubljana, Slovenia; University of Ljubljana, Faculty of Pharmacy, Chair of Clinical Biochemistry, Ljubljana, Slovenia. Electronic address: sasa.cucnik@kclj.si.
Atherosclerosis ; 291: 1-8, 2019 12.
Article en En | MEDLINE | ID: mdl-31629987
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Vasos Coronarios / Células Endoteliales / Anticuerpos Neutralizantes / Infliximab / Inhibidores del Factor de Necrosis Tumoral Límite: Humans Idioma: En Revista: Atherosclerosis Año: 2019 Tipo del documento: Article País de afiliación: Eslovenia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Vasos Coronarios / Células Endoteliales / Anticuerpos Neutralizantes / Infliximab / Inhibidores del Factor de Necrosis Tumoral Límite: Humans Idioma: En Revista: Atherosclerosis Año: 2019 Tipo del documento: Article País de afiliación: Eslovenia